12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's pre-market session, several healthcare stocks experienced significant movements. Longboard Pharmaceuticals (LBPH) saw a 157.0% increase to $15.5, while Cue Health (HLTH) rose by 40.61% to $0.23. Voyager Therapeutics (VYGR) and NGM Biopharmaceuticals (NGM) also saw substantial gains. Conversely, China SXT Pharmaceuticals (SXTC) and Corcept Therapeutics (CORT) faced steep declines, along with Aditxt (ADTX) and others.
January 02, 2024 | 1:05 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Corcept Therapeutics stock decreased by 32.58% to $21.9, with a market cap of $2.2 billion.
The significant drop in Corcept's stock price suggests a negative event or outlook, which could result in continued short-term decline.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
China SXT Pharmaceuticals stock fell by 32.8% to $2.67, with a market cap of $1.5 million.
The sharp decline in pre-market trading could indicate negative news or investor sentiment, likely leading to a short-term downtrend.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Cue Health stock increased by 40.61% to $0.23, with a market cap of $35.3 million.
The substantial pre-market rise indicates a strong positive development for the company, potentially driving further short-term gains.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Longboard Pharmaceuticals shares soared by 157.0% to $15.5 in pre-market trading, with a market cap of $369.7 million.
The significant pre-market increase in share price suggests positive investor sentiment or reaction to recent company news, which could lead to continued short-term upward momentum.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
NGM Biopharmaceuticals stock rose 26.89% to $1.09, with a market cap of $90.1 million.
The increase in NGM's stock price suggests positive market sentiment that could lead to short-term upward price movement.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Voyager Therapeutics stock climbed 27.72% to $10.78, with a market cap of $474.2 million.
The notable increase in stock price could reflect investor optimism, potentially leading to further short-term appreciation.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80